Eczema Study Treatment
Study Number: C22-D036
Study Location:
Dallas Research Center: 1801 N. Glenville Dr., Suite 250 Richardson, Texas 75081
Compensation: Up to $475
Gender:
Males and Females
Age:
12-65
Skin Type:
I-VI
Study Description:
This study is being conducted to assess how effective and safe a skin care regimen is when used over the course of 12 weeks by male and female children and adults with moderate eczema and who have experienced at least 2 flare-ups within the 3 months prior to screening, with the last flare within 6 weeks of baseline, including those with at least 1 active eczema lesion on the face, neck, torso, arms, or legs.
Study Requirements:
- Must have eczema (ectopic dermatitis) and have had at least 2 flare-ups within the last 6 weeks – 3 months.
- If under 18 years of age, a parent/legal guardian must present proof of guardianship at time of screening.
- Men with eczema on the face and neck must be willing to shave the area during the study
- Cannot have any active or dormant skin diseases or be on any medications that the study investigator determines could impact results of the study.
- Cannot currently be participating in another study at SGS, another research facility or doctor’s office or have participated on a study involving the eczema treatment area at SGS, another research facility or doctor’s office within the past 2 weeks.
This study has completed enrollment! Please check out our other studies.